Table. 2 The correlation between LINC00261 expression and clinicopathological features of patients with pancreatic cancer from our own center.
Characteristics | n = 87 | Expression of linc00261 | P value | |
|---|---|---|---|---|
Low expression | High expression | |||
Gender | ||||
 Male | 35 (40.2%) | 18 (51.4%) | 17 (48.6%) | 0.630 |
 Female | 52 (59.8%) | 28 (53.8%) | 24 (46.2%) |  |
Age (years) | ||||
 ≥60 | 55 (63.2%) | 29 (52.7%) | 26 (47.3%) | 0.810 |
 <60 | 32 (36.8%) | 17 (53.1%) | 15 (46.9%) |  |
Pathologic stage | ||||
 I | 19 (21.8%) | 6 (31.6%) | 13 (68.4%) | 0.012* |
 II | 31 (35.6%) | 16 (51.6%) | 15 (48.4%) |  |
 III + IV | 37 (42.6%) | 25 (67.6%) | 12 (32.4%) |  |
T stage | ||||
 T1 + T2 | 32 (36.8%) | 11 (34.4%) | 21 (65.6%) | 0.006* |
 T3 + T4 | 55 (63.2%) | 35 (63.6%) | 20 (36.4%) |  |
N stage | ||||
 N0 | 33 (37.9%) | 13 (39.4%) | 20 (60.6%) | 0.161 |
 N1 | 42 (48.3%) | 23 (54.8%) | 19 (45.2%) |  |
 N2 | 12 (13.8%) | 8 (66.7%) | 4 (33.3%) |  |
M stage | ||||
 M0 | 76 (87.4%) | 39 (51.3%) | 37 (48.7%) | 0.810 |
 M1 | 11 (12.6%) | 5 (45.5%) | 6 (54.5%) |  |
